Acalabrutinib plus obinutuzumab shows superior long-term outcomes in treatment-naive chronic lymphocytic leukemia.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/this-drug-combo-future-chronic-lymphocytic-leukemia-care-2025a1000rdh?src=rss
Author :
Publish date : 2025-10-10 12:18:00
Copyright for syndicated content belongs to the linked Source.